Health Canada Approves Merck’s Keytruda With Enfortumab Vedotin For Bladder Cancer

KENILWORTH (NJ) (dpa-AFX) - Merck & Co., Inc. (MRK), known as MSD outside the United States and Canada, said on Wednesday that Health Canada approved its cancer drug Keytruda in combination with e...